+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Defibrillators - Global Market Trajectory & Analytics

  • ID: 2832335
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik GmbH & Co. KG
  • GE Healthcare Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Physio-Control Inc.
Global Cardiac Defibrillators Market to Reach $14.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Cardiac Defibrillators estimated at US$11.2 Billion in the year 2020, is projected to reach a revised size of US$14.9 Billion by 2027, growing at a CAGR of 4.2% over the period 2020-2027. Implantable/Internal Cardiac Defibrillator, one of the segments analyzed in the report, is projected to record 2.8% CAGR and reach US$7.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the External Cardiac Defibrillator segment is readjusted to a revised 5.9% CAGR for the next 7-year period.







The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 4.1% CAGR

The Cardiac Defibrillators market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Select Competitors (Total 30 Featured):
  • Abbott Laboratories
  • Biotronik GmbH & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • GE Healthcare Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Physio-Control Inc.
  • St. Jude Medical Inc.
  • Zoll Medical Corporation
Frequently Asked Questions about the Global Market for Cardiac Defibrillators

What is the estimated value of the Global Market for Cardiac Defibrillators?

The Global Market for Cardiac Defibrillators was estimated to be valued at $11.2 Billion in 2020.

What is the growth rate of the Global Market for Cardiac Defibrillators?

The growth rate of the Global Market for Cardiac Defibrillators is 4.2%, with an estimated value of $14.9 Billion by 2027.

What is the forecasted size of the Global Market for Cardiac Defibrillators?

The Global Market for Cardiac Defibrillators is estimated to be worth $14.9 Billion by 2027.

Who are the key companies in the Global Market for Cardiac Defibrillators?

Key companies in the Global Market for Cardiac Defibrillators include Abbott Laboratories, Biotronik GmbH & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, GE Healthcare Ltd., Medtronic, Inc., Philips Healthcare, Physio and St. Jude Medical Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik GmbH & Co. KG
  • GE Healthcare Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Physio-Control Inc.

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Cardiac Defibrillators - An Effective Device for SCA
  • Current and Future Analysis
  • Recent Market Activity
  • Key Market Drivers and Restraints
  • Cardiovascular Disease - An Overview
  • CVD - Facts & Figures
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
  • Abbott Laboratories (USA)
  • Biotronik GmbH & Co. KG (Germany)
  • Boston Scientific Corporation (USA)
  • Cardiac Science Corporation (USA)
  • Defibtech, LLC (USA)
  • HeartSine® Technologies, Inc. (USA)
  • Medtronic, Inc. (USA)
  • Nihon Kohden Corporation (Japan)
  • Philips Healthcare (The Netherlands)
  • Physio-Control, Inc. (USA)
  • MicroPort Scientific Corporation (China)
  • Zoll Medical Corporation (USA)

3. MARKET TRENDS & DRIVERS
  • Emphasis on Public Access Defibrillation Drives Demand for AEDs
  • Focus Grows on Building Compact Defibrillators
  • Wearable Cardiac Defibrillators Gain Interest
  • Wearables Found to be SuiTable for Young Patients
  • ICDs with MRI Compatibility - An Important Development
  • Technology Advancements in ICD Space
  • Manufacturers Focus on Extended Battery Life
  • S-ICDs - A Promising Alternative to SCA Treatment
  • Extravascular ICD solutions Emerge as a Growing Area of Interest
  • AED Manufacturers Focus on Performance and Safety
  • Manufacturers Integrate Other Technologies in Defibrillators
  • Advanced Waveforms Take Precedence

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Cardiac Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Cardiac Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Cardiac Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Implantable/Internal Cardiac Defibrillator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Implantable/Internal Cardiac Defibrillator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Implantable/Internal Cardiac Defibrillator by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for External Cardiac Defibrillator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for External Cardiac Defibrillator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for External Cardiac Defibrillator by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 13: World Current & Future Analysis for Public Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Public Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Public Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 16: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 19: USA Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: USA Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: USA 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 22: USA Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 23: USA Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: USA 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
  • Table 25: Canada Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: Canada Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: Canada 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 28: Canada Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: Canada Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: Canada 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
  • Table 31: Japan Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Japan Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: Japan 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 34: Japan Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Japan Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: Japan 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
  • Table 37: China Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: China Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: China 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 40: China Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: China Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: China 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
  • Table 43: Europe Current & Future Analysis for Cardiac Defibrillators by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 44: Europe Historic Review for Cardiac Defibrillators by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: Europe 15-Year Perspective for Cardiac Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 46: Europe Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Europe Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: Europe 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 49: Europe Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 51: Europe 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
  • Table 52: France Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 53: France Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 54: France 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 55: France Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: France Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 57: France 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
  • Table 58: Germany Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 59: Germany Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 60: Germany 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 61: Germany Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Germany Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 63: Germany 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
  • Table 64: Italy Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 65: Italy Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 66: Italy 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 67: Italy Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 68: Italy Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 69: Italy 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
  • Table 70: UK Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 71: UK Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 72: UK 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 73: UK Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 74: UK Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 75: UK 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
  • Table 76: Rest of Europe Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 77: Rest of Europe Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 78: Rest of Europe 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 79: Rest of Europe Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 80: Rest of Europe Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 81: Rest of Europe 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
  • Table 82: Asia-Pacific Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 83: Asia-Pacific Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 84: Asia-Pacific 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 85: Asia-Pacific Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 86: Asia-Pacific Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 87: Asia-Pacific 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
  • Table 88: Rest of World Current & Future Analysis for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 89: Rest of World Historic Review for Cardiac Defibrillators by Product Segment - Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 90: Rest of World 15-Year Perspective for Cardiac Defibrillators by Product Segment - Percentage Breakdown of Value Sales for Implantable/Internal Cardiac Defibrillator and External Cardiac Defibrillator for the Years 2012, 2020 & 2027
  • Table 91: Rest of World Current & Future Analysis for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 92: Rest of World Historic Review for Cardiac Defibrillators by End-Use - Hospitals, Public Access and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 93: Rest of World 15-Year Perspective for Cardiac Defibrillators by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Access and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 30
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Biotronik GmbH & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • GE Healthcare Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Physio-Control Inc.
  • St. Jude Medical Inc.
  • Zoll Medical Corporation
Note: Product cover images may vary from those shown

RELATED TAGS

RELATED PRODUCTS

External Defibrillator Market Research Report: By Patient Type, End User - Global Industry Revenue Forecast to 2030 - Product Image

External Defibrillator Market Research Report: By Patient Type, End User - Global Industry Revenue Forecast to 2030

  • Report
  • 170 Pages
  • Region: Global
Defibrillators Market Size, Share, Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis - Product Image

Defibrillators Market Size, Share, Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis

  • Report
  • 145 Pages
  • Region: Global
Cardiac Rhythm Management Devices Market Research Report by Product (Cardiac Resynchronization Therapy, Defibrillators, and Pacemakers), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Product Image

Cardiac Rhythm Management Devices Market Research Report by Product (Cardiac Resynchronization Therapy, Defibrillators, and Pacemakers), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • 215 Pages
  • Region: Global
Defibrillators Market Research Report by Type (External Defibrillators and Implantable Cardioverter Defibrillators), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Product Image

Defibrillators Market Research Report by Type (External Defibrillators and Implantable Cardioverter Defibrillators), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • 211 Pages
  • Region: Global
Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region (North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026 - Product Image

Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region (North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026

  • Report
  • 219 Pages
  • Region: Global
Copyright © 2002-2022 Research and Markets. All Rights Reserved.